Oral phosphate binding agents have been used for the treatment of hyperphosphatemia in dialysis patients for decades. Their safety record was marred in the early 1980's by reports of aluminium ...

The treatment of hyperphosphatemia was intensified by the additional mealtime administration of phosphate binders, such as aluminium hydroxide and calcium carbonate. Phosphate accumulation was ...